Doxycycline + ceftriaxone (n = 61), (n (%)) | Doxycycline + cefixime (n = 64), (n (%)) | OR (95% CI) | p value | |
---|---|---|---|---|
Skin rash | 3 (4.92) | 1 (1.56) | 3.23 (0.25–173.57) | 0.357 |
Eosinophilia | 2 (3.28) | 3 (4.69) | 0.69 (0.06–6.26) | 1 |
Leukopenia | 2 (3.28) | 3 (4.69) | 0.69 (0.06–6.26) | 1 |
Increased serum transaminases | 4 (6.56) | 2 (3.13) | 2.16 (0.3–24.77) | 0.432 |
Abdominal distention | 1 (1.64) | 3 (4.69) | 0.34 (0.01–4.39) | 0.619 |
Diarrhea | 3 (4.92) | 7 (10.94) | 0.42 (0.07–1.97) | 0.325 |
Abdominal pain | 2 (3.28) | 6 (9.38) | 0.33 (0.03–1.95) | 0.274 |
Vomiting | 1 (1.64) | 4 (6.25) | 0.25 (0–2.65) | 0.366 |
Pain at injection site | 6 (9.84) | |||
Tenderness at injection site | 1 (1.64) |